Efficacy and safety of ceftazidime-avibactam versus tigecycline in the treatment of pneumonia caused by carbapenem-resistant Klebsiella pneumoniae
Background Carbapenem-resistant Klebsiella pneumoniae (CRKP) causes severe high-mortality nosocomial pneumonia. Ceftazidime-avibactam (CAZ-AVI) and tigecycline (TGC) are key CRKP antimicrobials, but direct comparative efficacy and safety data are limited. This retrospective study compared clinical efficacy and safety o...